tbuckley/cabot-search huggingface dataset:
Changing Profiles of Service Sectors Used for Mental Health Care in the United States
Authors: Philip S Wang, Olga Demler, Mark Olfson, Harold A Pincus, Kenneth B Wells, Ronald C Kessler
Journal: American Journal of Psychiatry (2006)

Redesigning the fragmented U.S. mental health care system requires knowing how service sectors share responsibility for individuals' mental health needs.Twelve-month DSM-IV mental disorders and their severity were assessed in respondents ages 15-54 from the National Comorbidity Survey (NCS) in 1990-1992 (N=5,388) and the NCS Replication in 2001-2003 (N=4,319). Six profiles involving potentially multiple service sectors were defined, including those in which pharmacotherapy plus psychotherapy (psychiatry profile, general medical with other mental health specialty profile), single modalities (general medical only profile, other mental health specialty only profile), or neither modality (human services only profile, complementary/alternative medicine only profile) could potentially have been received. The use of profiles was compared between surveys.The general medical only profile experienced the largest proportional increase (153%) between surveys and is now the most common profile. The psychiatry profile also increased (29%), as did the general medical with other mental health specialty profile (72%). The other mental health specialty only (-73%), the complementary/alternative medicine only (-132%), and the human services only (-137%) profiles all decreased in use. The elderly, women, minorities, the less educated, and rural dwellers were less likely to use profiles capable of delivering pharmacotherapies and/or psychotherapies.How service sectors share responsibility for peoples' mental health care is changing, with more care falling to general medical providers rather than specialists. Efforts are required to ensure that people who would benefit have access to the necessary treatment modalities.
Anaplastic large‐cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL‐6 serum levels after long‐term immunosuppressive therapy
Authors: Takashi Shimamoto, Shigefumi Hayashi, Keiko Ando, Makoto Yguchi, Keisuke Miyazawa, Yukihiko Kimura, Kiyoshi Mukai, Hiromi Serizawa, Kazuma Ohyashiki
Journal: American Journal of Hematology (2001)

We report a patient with anaplastic large-cell lymphoma (ALCL) who has been given immunosuppressive therapy for Evans syndrome for 10 years. He was admitted with spike fever, intra-abdominal lymphadenopathy, and multiple liver masses. Examination of biopsy specimens obtained by para-aortic lymph nodes and liver masses resulted in a diagnosis of ALCL. Immunohistochemically, these cells were reactive to anti-CD30 antibody but were not of B- or T-lineage. Bone marrow aspiration demonstrated the invasion of giant neoplastic cells and trilineage myelodysplasia. Because the patient showed severe inflammatory symptoms, we examined serum levels of various cytokines. Pretreatment levels of IL-6 and VEGF in this patient were significantly elevated compared to those of normal controls. He was treated with combination chemotherapy (ABVD regimen), achieving complete remmesion. Myelodysplasia and serum IL-6 and VEGF also normalized after treatment. We assumed that ALCL resulted from long-term immunosuppressive therapy and that the up-regulation of IL-6 and VEGF played a role in pathogenesis of this type of lymphoma. Am. J. Hematol. 66:49–52, 2001. © 2001 Wiley-Liss, Inc.
Gynecologic cancer
Authors: Somers H. Sturgis
Journal: JAMA (1962)

This is the third edition of a book that has been deservedly popular throughout the past decade and has found its place on the shelves not only of obstetricians and gynecologists, but also of surgeons and men in general medicine. In the previous two editions and the present volume, the author first stresses his impression that many, if not most, of the 30,000 deaths in the United States from gynecologic cancer may be unnecessary. The introduction provides the student with invaluable tables of incidence, probability, and mortality rates to substantiate the argument of curability of this disease and to refute any tendency of a group of nihilists to cry that there is no hope that earlier detection may give greater salvage rates. These facts and figures, as they are presented here, leave little to dispute Dr. Corscaden's determined point of view that earlier detection can and must give better salvage
Trial of Thomas Neill Cream.
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Parkinson Disease
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Skunk-associated human rabies
Authors: M. A. Hattwick
Journal: JAMA (1972)

In the United States since 1960, skunks have become the most frequently reported rabid animal and the most common source of human rabies. Four of the eight domestically acquired human cases of rabies reported since 1963 were caused by skunk bites; two of these occurred in 1970. This article presents data on these two cases and reviews the problem of skunk-associated human rabies. The patients were bitten while trying to capture wild skunks or while sleeping on the ground in unprotected sleeping bags. Only one patient received the full recommended postexposure prophylaxis consisting of antirabies serum and 21 doses of duck-embryo vaccine. After clinical symptoms of rabies develop, there is at present no specific antirabies therapy. Aggressive conservative care concentrating on prevention of the complications of the viral infection may, however, result in recovery.
Myocardial Infarctions
Journal: JAMA (1978)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
American Cancer Society guidelines for the early detection of cancer
Authors: R. A. Smith, C. J. Mettlin, K. J. Davis, H. Eyre
Journal: CA A Cancer Journal for Clinicians (2000)

This issue of CA inaugurates a yearly report on American Cancer Society guidelines for early detection of cancer in asymptomatic individuals. The current recommendations, which reflect almost 20 years of updates, cover screening recommendations for breast, colorectal, prostate, and cervical cancers, as well as for other cancers, depending on patient age, history, environmental and/or occupational exposures, etc. A key concept for both the general public and health providers is the distinction between public health recommendations regarding screening and decisions about early detection tests that might be undertaken on an individual basis. Although it is likely that current screening protocols will be supplanted by newer technologies, such as genetic and molecular markers of risk and disease, greater utilization of the technologies at hand will improve efforts toward establishing an organized and systematic approach to early cancer detection.
Physicochemical Properties of Some Organophosphates in Relation to Their Chronic Toxicity
Authors: V. H. Freed, R. Haque, D. Schmedding, R. Kohnert
Journal: Environmental Health Perspectives (1976)

Organophosphates in increasing amounts and wider varieties of molecular structure are being used to replace the organochlorine pesticides. It has been assumed that the organophosphates as a class would have a minimal chronic toxicity due to rapid hydrolysis and an unfavorable partitioning as regards to lipids. The physicochemical properties of a number of representative organophosphates were determined, including the octanol/water partition coeffecient, hydrolysis, and binding to proteins. Those having a halogenated aryl substitution were found to have partition coefficients not largely different from the organochlorines, suggesting the possibility of fat deposition. Certain of these compounds are sufficiently stable toward hydrolysis to allow bioaccumulation to occur. These preliminary findings appear to indicate a correlation between readily determined physical properties and the potential for chronic effects in this class of compounds.
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer
Authors: T.W. Kim, H.M. Chang, H.J. Kang, J.R. Lee, M.H. Ryu, J.H. Ahn, J.H. Kim, J.S. Lee, Y.K. Kang
Journal: Annals of Oncology (2003)
Addiction Medicine
Authors: Charles P. O'Brien
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
IFP News Section
Authors: Filipe Barbosa, Catarina Mota, Patrícia Patrício, Cristina Alcântara, Carlos Ferreira, António Barbosa, Marianne Heins, Hans Knoop, Gijs Bleijenberg, Tom Kindlon, Anna Bartak, Helene Andrea, Marieke D. Spreeuwenberg, Moniek Thunnissen, Uli M. Ziegler, Jack Dekker, Fleur Bouvy, Elisabeth F.M. Hamers, Alain Braillon, Anke M.M.A. Meerman, Theo Stijnen, Paul M.G. Emmelkamp, John S. Ogrodniczuk, Michel Leroy, Gwenolé Loas, Fernando Perez-Diaz, Fabrizio Schifano, Stefano D'Offizi, Michele Piccione, Ornella Corazza, Paolo Deluca, Zoe Davey, Giuditta Di Melchiorre, Lucia Di Furia, Magí Farré, Liv Flesland, Miia Mannonen, Aino Majava, Boudewijn Van Houdenhove, Patrick Luyten, Marco Chiesa, Rachel Sharp, Peter Fonagy, Stefan Priebe, Michelle Richardson, Maire Cooney, Oluwatoyin Adedeji, Rosemarie McCabe, Jan J.V. Busschbach, Roel Verheul, Stefania Pagani, Teuvo Peltoniemi, Holger Siemann, Arvid Skutle, Marta Torrens, Cinzia Pezzolesi, Peer van der Kreeft, Norbert Scherbaum, Julia Romanowska, Gerry Larsson, Maria Eriksson, Britt-Maj Wikström, Hugo Westerlund, Töres Theorell, Satz Mengensatzproduktion, Druck Reinhardt Druck Basel, Druck Reinhardt Druck Basel
Journal: Psychotherapy and Psychosomatics (2011)
Private patients and surgical training
Authors: R. M. Sade
Journal: JAMA (1977)

Inaccurate and occasionally inflammatory descriptions of the education of surgeons in recent news reports have produced unnecessary anxiety in many patients. For several months after a television program that presented surgical residents as inept students and their teachers as uncertain apologists, anxious patients asked me, "Doctor, will you do the operation?" Before a surgeon-educator can answer this question, he must have a clear concept of the purposes of surgical education and the nature of the surgeon-patient relationship. The nature of surgical treatment focuses a surgeon's education on two paramount skills: surgical technique and judgment of when and when not to operate. Development of both abilities requires progressively increasing responsibility for patient care during the period of surgical training. By the time his residency is completed, a surgeon must be competent to exercise sound surgical judgment, and he must possess adequate technical skill for independent practice. These goals were achieved readily
Massachusetts Department of Public Health
Authors: Joseph T. Walker
Journal: New England Journal of Medicine (1949)

IDENTIFICATION OF BLOODSTAINS — IIThe proof that a stain has been caused by blood is a significant step in its identification.1 To show that it has been caused by human blood is of much greater importance.Before the beginning of this century the characterization of the species origin of bloodstains was made solely on the basis of the morphology of the red cells. Although there are well recognized species differences in the size and shape of the intact mammalian erythrocyte, the effects of autolysis, hemolysis, drying and other mechanical distortion are such as to relegate this method of species . . .
THE UNCERTAINTIES OF PUBLIC HEALTH EFFORTS
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BCG and Cancer
Journal: JNCI Journal of the National Cancer Institute (1981)

Journal Article BCG and Cancer Get access Herbert J. Rapp, Sc.D., Herbert J. Rapp, Sc.D. Laboratory of Immunobiology Division of Cancer Biology and Diagnosis National Cancer InstituteBethesda, Maryland 20205 Search for other works by this author on: Oxford Academic PubMed Google Scholar Berton Zbar, M.D. Berton Zbar, M.D. Laboratory of Immunobiology Division of Cancer Biology and Diagnosis National Cancer InstituteBethesda, Maryland 20205 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 67, Issue 5, November 1981, Page 991, https://doi.org/10.1093/jnci/67.5.991 Published: 01 November 1981
Toxic effect of stramonium simulating LSD trip
Authors: J. N. DiGiacomo
Journal: JAMA (1968)

Four cases of stramonium poisoning in teen-agers secondary to ingestion of Asthmador asthmatic powder (stramonium-belladonna mixture) presented as LSD reactions. The clinical manifestations were acute brain syndrome and physical signs of atropinization. The effects of stramonium ingestion are similar to the effects of the ingestion of amphetamine and LSD, but in addition to the psychosis due to toxic reaction, the patient who has ingested stramonium typically has dry mucous membranes and is hot and flushed.
CONSERVATIVE SURGERY.
Authors: RICARDO ORTEGA
Journal: JAMA (1898)

The large number of maimed persons I have seen among railway employes, prompts me to make a few remarks with a view to enlisting co-operation in preventing the unnecessary mutilation of the injured. It is true that we frequently encounter ungrateful patients who blame us because the member we have saved, after toiling with it more than we would have been obliged to do had we resorted to amputation, is not in as good condition as it was before the accident. Others aver that we are not surgeons if we do not mutilate. This opinion, however, is of no importance when we are conscious of having done our best. It is the better plan to preserve all we can of an injured organism, even at the risk of retaining, for a time at least, that which may ultimately be an encumbrance. I have had cases when it seemed that to
Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes
Authors: N Enomoto
Journal: Hepatology (1991)

To clarify the pathogenetic role of acetaldehyde in the development of alcoholic liver disease, genotyping of aldehyde dehydrogenase-2 genes was performed and the clinical features of the alcoholic liver disease patients with different genotypes were compared. Genotyping of aldehyde dehydrogenase-2 was performed in 47 patients with alcoholic liver disease using the polymerase chain reaction and slot-blot hybridization. Of the 47 patients with alcoholic liver disease, 40 were homozygous for the normal aldehyde dehydrogenase-2 gene and the remaining seven cases were heterozygous for the normal and mutant aldehyde dehydrogenase-2 genes. No homozygote was found for the mutant aldehyde dehydrogenase-2 genes. Daily alcohol intake was less than 100 gm in all heterozygotes without relation to the type of alcoholic liver disease. On the other hand, all but four patients homozygotic for the normal aldehyde dehydrogenase-2 gene drank more than 100 gm alcohol/day. The mean daily alcohol intake in the heterozygotes was significantly lower than that in the normal homozygotes. The incidence of alcoholic fibrosis tended to be lower in the heterozygotes than in the normal homozygotes (14.2% vs. 52.5%). On the other hand, the incidence of alcoholic hepatitis and/or cirrhosis tended to be higher in the heterozygotes than in the normal homozygotes. These results indicate that alcoholic liver disease develops even with moderate amounts of alcohol intake in heterozygotes of the aldehyde dehydrogenase-2 genes, in which acetaldehyde metabolism in the liver is impaired and liver damage in the heterozygotes is more severe than that in the normal homozygotes, suggesting that habitual drinkers who are heterozygotes of the aldehyde dehydrogenase-2 genes may be at high risk for alcoholic liver disease. (HEPATOLOGY 1991;13:1071–1075.)
Violence-Related Attitudes and Behaviors of High School Students—New York City, 1992
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Polymyalgia Rheumatica
Authors: Selvan Davison
Journal: JAMA (1979)

<h3>To the Editor.—</h3> The editorial inThe Journalby George Ehrlich, MD (240:57, 1978), and the clinical report by Miller and Stevens (240:27, 1978) raise the question as to whether polymyalgia rheumatica should still be considered a diagnostic entity. Ehrlich compares polymyalgia rheumatica with rheumatoid arthritis of the elderly with the "bilateral shoulder-hand syndrome" type of presentation and concludes that these two may represent the same disease process and no distinction be made between them. He suggests that polymyalgia rheumatica should possibly be considered a part of the syndrome of rheumatoid arthritis of the elderly. His approach raises a number of problems: The presence of active synovitis has been considered sine qua non of rheumatoid arthritis since the American Rheumatism Association criteria for rheumatoid arthritis were proposed. The removal of this criterion would set back the classfication of rheumatic diseases more than 20 years. The observation of O'Duffy<sup>1</sup>referred